• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

溶血磷脂酸受体-5负向调节人肉瘤细胞系的细胞运动和侵袭活性。

Lysophosphatidic acid receptor-5 negatively regulates cell motile and invasive activities of human sarcoma cell lines.

作者信息

Dong Yan, Hirane Miku, Araki Mutsumi, Fukushima Nobuyuki, Honoki Kanya, Tsujiuchi Toshifumi

机构信息

Division of Cancer Biology and Bioinformatics, Department of Life Science, Faculty of Science and Engineering, Kinki University, 3-4-1, Kowakae, Higashiōsaka, Osaka, 577-8502, Japan.

出版信息

Mol Cell Biochem. 2014 Aug;393(1-2):17-22. doi: 10.1007/s11010-014-2042-2. Epub 2014 Mar 28.

DOI:10.1007/s11010-014-2042-2
PMID:24676544
Abstract

LPA signaling via LPA receptors [LPA receptor-1 (LPA1)-LPA6] mediates the several cellular responses in cancer cells, including cell motility and invasion. In the present study, to investigate a role of LPA5 in the cell motile and invasive activities of sarcoma cells, LPAR5 knockdown (HOSL5 and HT1080L5) cells were generated from human osteosarcoma HOS and fibrosarcoma HT1080 cells, respectively. In cell motility assays with cell culture inserts, HOSL5 and HT1080L5 cells indicated the high cell motile activities, compared with control cells. The cell invasive activities of HOSL5 and HT1080L5 cells were significantly higher than those of control cells. Moreover, the activities of matrix metalloproteinase (MMP)-2 and MMP-9 were measured by gelatin zymography. MMP-2 was significantly activated in HOSL5 cells, but not MMP-9. The elevated activities of MMP-2 and MMP-9 were found in HT1080L5 cells, in comparison with control cells. These results suggest that LPA signaling via LPA5 negatively regulates the cell motile and invasive activities of human sarcoma cells.

摘要

溶血磷脂酸(LPA)通过LPA受体[LPA受体-1(LPA1)-LPA6]介导癌细胞中的多种细胞反应,包括细胞迁移和侵袭。在本研究中,为了探究LPA5在肉瘤细胞的细胞迁移和侵袭活性中的作用,分别从人骨肉瘤HOS细胞和纤维肉瘤HT1080细胞中生成了LPAR5敲低(HOSL5和HT1080L5)细胞。在使用细胞培养插入物的细胞迁移试验中,与对照细胞相比,HOSL5和HT1080L5细胞表现出较高的细胞迁移活性。HOSL5和HT1080L5细胞的细胞侵袭活性显著高于对照细胞。此外,通过明胶酶谱法测定基质金属蛋白酶(MMP)-2和MMP-9的活性。MMP-2在HOSL5细胞中被显著激活,但MMP-9未被激活。与对照细胞相比,HT1080L5细胞中发现MMP-2和MMP-9的活性升高。这些结果表明,通过LPA5的LPA信号传导负调节人肉瘤细胞的细胞迁移和侵袭活性。

相似文献

1
Lysophosphatidic acid receptor-5 negatively regulates cell motile and invasive activities of human sarcoma cell lines.溶血磷脂酸受体-5负向调节人肉瘤细胞系的细胞运动和侵袭活性。
Mol Cell Biochem. 2014 Aug;393(1-2):17-22. doi: 10.1007/s11010-014-2042-2. Epub 2014 Mar 28.
2
Loss of lysophosphatidic acid receptor-3 suppresses cell migration activity of human sarcoma cells.溶血磷脂酸受体-3的缺失抑制人肉瘤细胞的细胞迁移活性。
J Recept Signal Transduct Res. 2012 Dec;32(6):328-34. doi: 10.3109/10799893.2012.738689. Epub 2012 Nov 20.
3
Inhibitory effects of lysophosphatidic acid receptor-5 on cellular functions of sarcoma cells.溶血磷脂酸受体-5对肉瘤细胞细胞功能的抑制作用。
Growth Factors. 2014 Jun;32(3-4):117-22. doi: 10.3109/08977194.2014.911294. Epub 2014 May 6.
4
Lysophosphatidic acid receptor-5 negatively regulates cellular responses in mouse fibroblast 3T3 cells.溶血磷脂酸受体-5负调控小鼠成纤维细胞 3T3 细胞的细胞反应。
Biochem Biophys Res Commun. 2014 Apr 4;446(2):585-9. doi: 10.1016/j.bbrc.2014.03.016. Epub 2014 Mar 12.
5
LPA-mediated signaling induced by endothelial cells and anticancer drug regulates cellular functions of osteosarcoma cells.LPA 介导的信号通路由内皮细胞和抗癌药物诱导,调节骨肉瘤细胞的细胞功能。
Exp Cell Res. 2020 Mar 1;388(1):111813. doi: 10.1016/j.yexcr.2020.111813. Epub 2020 Jan 2.
6
Lysophosphatidic acid (LPA) signaling via LPA and LPA negatively regulates cell motile activities of colon cancer cells.溶血磷脂酸(LPA)通过LPA信号通路对结肠癌细胞的细胞运动活性起负向调节作用。
Biochem Biophys Res Commun. 2017 Jan 29;483(1):652-657. doi: 10.1016/j.bbrc.2016.12.088. Epub 2016 Dec 18.
7
Modulation of chemoresistance by lysophosphatidic acid (LPA) signaling through LPA in melanoma cells treated with anticancer drugs.通过在接受抗癌药物治疗的黑素瘤细胞中 LPA 信号对溶脂性磷脂酸(LPA)的化学耐药性进行调节。
Biochem Biophys Res Commun. 2019 Sep 17;517(2):359-363. doi: 10.1016/j.bbrc.2019.07.092. Epub 2019 Jul 27.
8
Lysophosphatidic acid signaling via LPA and LPA regulates cellular functions during tumor progression in pancreatic cancer cells.溶血磷脂酸通过LPA和LPA信号通路在胰腺癌细胞的肿瘤进展过程中调节细胞功能。
Exp Cell Res. 2017 Mar 1;352(1):139-145. doi: 10.1016/j.yexcr.2017.02.007. Epub 2017 Feb 8.
9
Lysophosphatidic acid receptor-2 (LPA) and LPA regulate cellular functions during tumor progression in fibrosarcoma HT1080 cells.溶血磷脂酸受体-2 (LPA) 和 LPA 在纤维肉瘤 HT1080 细胞的肿瘤进展过程中调节细胞功能。
Biochem Biophys Res Commun. 2018 Sep 18;503(4):2698-2703. doi: 10.1016/j.bbrc.2018.08.026. Epub 2018 Aug 7.
10
Enhanced cellular functions through induction of LPA by cisplatin in fibrosarcoma HT1080 cells.顺铂诱导纤维肉瘤HT1080细胞产生溶血磷脂酸从而增强细胞功能。
Mol Cell Biochem. 2017 Jul;431(1-2):29-35. doi: 10.1007/s11010-017-2971-7. Epub 2017 Feb 15.

引用本文的文献

1
Unveiling the therapeutic promise: exploring Lysophosphatidic Acid (LPA) signaling in malignant bone tumors for novel cancer treatments.揭示治疗潜力:探索恶性骨肿瘤中的溶血磷脂酸 (LPA) 信号转导,以寻求新型癌症治疗方法。
Lipids Health Dis. 2024 Jun 28;23(1):204. doi: 10.1186/s12944-024-02196-9.
2
Roles of lysophosphatidic acid (LPA) receptor-mediated signaling in cancer cell biology.溶血磷脂酸(LPA)受体介导的信号通路在癌细胞生物学中的作用。
J Bioenerg Biomembr. 2024 Aug;56(4):475-482. doi: 10.1007/s10863-024-10028-9. Epub 2024 Jun 18.
3
Emerging roles of lysophosphatidic acid receptor subtype 5 (LPAR5) in inflammatory diseases and cancer.

本文引用的文献

1
Diverse effects of LPA receptors on cell motile activities of cancer cells.溶血磷脂酸(LPA)受体对癌细胞细胞运动活性的多种影响。
J Recept Signal Transduct Res. 2014 Jun;34(3):149-53. doi: 10.3109/10799893.2013.876042. Epub 2014 Jan 24.
2
Lysophosphatidic acid receptors in cancer pathobiology.溶血磷脂酸受体在癌症病理生物学中的作用。
Histol Histopathol. 2014 Mar;29(3):313-21. doi: 10.14670/HH-29.313. Epub 2013 Nov 6.
3
Inhibitory effects of LPA1 on cell motile activities stimulated by hydrogen peroxide and 2,3-dimethoxy-1,4-naphthoquinone in fibroblast 3T3 cells.
溶血磷脂酸受体亚型 5(LPAR5)在炎症性疾病和癌症中的新兴作用。
Pharmacol Ther. 2023 May;245:108414. doi: 10.1016/j.pharmthera.2023.108414. Epub 2023 Apr 13.
4
LPAR5 confers radioresistance to cancer cells associated with EMT activation via the ERK/Snail pathway.LPAR5 通过 ERK/Snail 通路赋予 EMT 激活相关的癌细胞放射抗性。
J Transl Med. 2022 Oct 5;20(1):456. doi: 10.1186/s12967-022-03673-4.
5
Identification of prognostic biomarkers associated with metastasis and immune infiltration in osteosarcoma.骨肉瘤中与转移和免疫浸润相关的预后生物标志物的鉴定
Oncol Lett. 2021 Mar;21(3):180. doi: 10.3892/ol.2021.12441. Epub 2021 Jan 6.
6
Lysophosphatidic Acid Receptor 5 (LPAR5) Plays a Significance Role in Papillary Thyroid Cancer via Phosphatidylinositol 3-Kinase/Akt/Mammalian Target of Rapamycin (mTOR) Pathway.溶血磷脂酸受体 5(LPAR5)通过磷脂酰肌醇 3-激酶/蛋白激酶 B/雷帕霉素靶蛋白(mTOR)通路在甲状腺乳头状癌中发挥重要作用。
Med Sci Monit. 2020 Jan 6;26:e919820. doi: 10.12659/MSM.919820.
7
Genetic expression profile-based screening of genes and pathways associated with papillary thyroid carcinoma.基于基因表达谱的甲状腺乳头状癌相关基因和通路筛选
Oncol Lett. 2018 Nov;16(5):5723-5732. doi: 10.3892/ol.2018.9342. Epub 2018 Aug 21.
8
Bioinformatic analysis and identification of potential prognostic microRNAs and mRNAs in thyroid cancer.甲状腺癌中潜在预后性微小RNA和信使核糖核酸的生物信息学分析与鉴定
PeerJ. 2018 May 4;6:e4674. doi: 10.7717/peerj.4674. eCollection 2018.
LPA1 对成纤维细胞 3T3 中过氧化氢和 2,3-二甲氧基-1,4-萘醌刺激的细胞迁移活动的抑制作用。
Biochem Biophys Res Commun. 2013 Nov 8;441(1):47-52. doi: 10.1016/j.bbrc.2013.10.009. Epub 2013 Oct 14.
4
Loss of lysophosphatidic acid receptor-3 suppresses cell migration activity of human sarcoma cells.溶血磷脂酸受体-3的缺失抑制人肉瘤细胞的细胞迁移活性。
J Recept Signal Transduct Res. 2012 Dec;32(6):328-34. doi: 10.3109/10799893.2012.738689. Epub 2012 Nov 20.
5
Opposite roles of LPA1 and LPA3 on cell motile and invasive activities of pancreatic cancer cells.溶血磷脂酸受体1(LPA1)和溶血磷脂酸受体3(LPA3)在胰腺癌细胞的细胞运动和侵袭活性中发挥相反作用。
Tumour Biol. 2012 Oct;33(5):1739-44. doi: 10.1007/s13277-012-0433-0. Epub 2012 Jun 8.
6
Targeted deletion of LPA5 identifies novel roles for lysophosphatidic acid signaling in development of neuropathic pain.靶向敲除 LPA5 鉴定出溶血磷脂酸信号在神经病理性疼痛发展中的新作用。
J Biol Chem. 2012 May 18;287(21):17608-17617. doi: 10.1074/jbc.M111.330183. Epub 2012 Mar 29.
7
Lysophosphatidic acid receptor-3 increases tumorigenicity and aggressiveness of rat hepatoma RH7777 cells.溶血磷脂酸受体 3 增强大鼠肝癌 RH7777 细胞的致瘤性和侵袭性。
Mol Carcinog. 2013 Apr;52(4):247-54. doi: 10.1002/mc.21851. Epub 2011 Dec 7.
8
Differential function of lysophosphatidic acid receptors in cell proliferation and migration of neuroblastoma cells.溶血磷脂酸受体在神经母细胞瘤细胞增殖和迁移中的差异功能。
Cancer Lett. 2012 Mar;316(1):91-6. doi: 10.1016/j.canlet.2011.10.030. Epub 2011 Oct 26.
9
Possible involvement of lysophosphatidic acid receptor-5 gene in the acquisition of growth advantage of rat tumor cells.可能涉及溶血磷脂酸受体-5 基因在大鼠肿瘤细胞获得生长优势中的作用。
Mol Carcinog. 2011 Aug;50(8):635-42. doi: 10.1002/mc.20750. Epub 2011 Mar 3.
10
Loss of lysophosphatidic acid receptor-3 enhances cell migration in rat lung tumor cells.缺失溶血磷脂酸受体-3 可增强大鼠肺肿瘤细胞的迁移。
Biochem Biophys Res Commun. 2011 Feb 18;405(3):450-4. doi: 10.1016/j.bbrc.2011.01.051. Epub 2011 Jan 19.